Bringing the fundamentals into focus…
Back to Cellectis S.A.
How Cellectis S.A. stacks up
CLLS · against 113 other Healthcare companies of similar size
Profitability
22/ 100
Below the middle of the pack.
Ranked #63 of 114 · scores higher than 44% of peers
Bars: peers in each 10-point band of the profitability score16 peers with a profitability score of 20–29, including CLLS · Click a bar to see the companies
Why profitability scores 22?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 83% of peers. Operating margin: -45.3% vs peer median 7.1%
- a lower return on assets: weaker than 76% of peers. Return on assets: -11.7% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = CLLS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CLLS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 82 reported | Not reported | -13.4% | — | — | 33% |
| Operating marginHigher is better · 104 reported | -45.3% | -6.1% | 36% | 33% | |
| Return on assetsHigher is better · 120 reported | -11.7% | -6.8% | 41% | 33% | |
| Return on equityHigher is better · 110 reported | -94.5% | -12.3% | 13% | Context only | |
| Gross marginHigher is better · 122 reported | 100.0% | 42.5% | 97% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CLLS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 59 | 200M USD | 26 | 30 | |
| 60 | 191M USD | 25 | 38 | |
| 61 | 84M CAD (≈$61M) | 23 | 24 | |
| 61 | 107M USD | 23 | 26 | |
| 63 | 110M USD | 22 | 38 | |
| 63 | 124M USD | 22 | 31 | |
| 65 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 66 | 429M HKD (≈$55M) | 20 | 20 | |
| 66 | 106M EUR (≈$116M) | 20 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score